FDA’s Role
Ongoing discussions with Community and Industry
1999 letter to Sponsors re: use of ɭ investigational agent
Labeling and other regulatory incentives
- Accelerated approval, priority review
Consensus about need for FDA-sponsored “working” meeting on this topic